Приказ основних података о документу
Naturally occurring compounds in differentiation based therapy of cancer.
dc.creator | Mijatović, Sanja | |
dc.creator | Bramanti, Alessia | |
dc.creator | Nicoletti, Ferdinando | |
dc.creator | Fagone, Paolo | |
dc.creator | Kaluđerović, Goran N. | |
dc.creator | Maksimović-Ivanić, Danijela | |
dc.date.accessioned | 2018-05-03T09:30:29Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | http://linkinghub.elsevier.com/retrieve/pii/S0734975018300739 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/29656090 | |
dc.identifier.uri | https://radar.ibiss.bg.ac.rs/handle/123456789/3045 | |
dc.description.abstract | Differentiation of cancer cells entails the reversion of phenotype from malignant to the original. The conversion to cell type characteristic for another tissue is named transdifferentiation. Differentiation/transdifferentiation of malignant cells in high grade tumor mass could serve as a nonaggressive approach that potentially limits tumor progression and augments chemosensitivity. While this therapeutic strategy is already being used for treatment of hematological cancers, its feasibility for solid malignancies is still debated. We will presently discuss the natural compounds that show these properties, with focus on anthraquinones from Aloe vera, Senna, Rheum sp. and hop derived prenylflavonoids. | en |
dc.relation | info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173013/RS// | |
dc.relation | IRCCS Centro Neurolesi “Bonino Pulejo”, Messina-Italy | |
dc.rights | restrictedAccess | |
dc.source | Biotechnology Advances | |
dc.subject | Aloe emodin | |
dc.subject | Blood tumors | |
dc.subject | Brain tumors | |
dc.subject | Cancer | |
dc.subject | Chemotherapy | |
dc.subject | Differentiation based therapies | |
dc.subject | Isoxanthohumol | |
dc.subject | Naturally occurring compounds | |
dc.subject | Neurooncology | |
dc.subject | Solid tumors | |
dc.subject | Transdifferentiation | |
dc.title | Naturally occurring compounds in differentiation based therapy of cancer. | en |
dc.type | article | en |
dc.rights.license | ARR | |
dcterms.abstract | Мијатовић, Сања; Калуђеровић, Горан Н.; Максимовић-Иванић, Данијела; Браманти, Aлессиа; Ницолетти, Фердинандо; Фагоне, Паоло; | |
dc.rights.holder | © 2018 Elsevier Inc. | |
dc.identifier.doi | 10.1016/j.biotechadv.2018.04.001 | |
dc.identifier.pmid | 29656090 | |
dc.identifier.scopus | 2-s2.0-85045557392 | |
dc.identifier.wos | 000443662700005 | |
dc.citation.apa | Mijatović, S., Bramanti, A., Nicoletti, F., Fagone, P., Kaluđerović, G. N., & Maksimović-Ivanić, D. (2018). Naturally occurring compounds in differentiation based therapy of cancer. Biotechnology Advances, DOI:10.1016/j.biotechadv.2018.04.001. | |
dc.citation.vancouver | Mijatović S, Bramanti A, Nicoletti F, Fagone P, Kaluđerović GN, Maksimović-Ivanić D. Naturally occurring compounds in differentiation based therapy of cancer. Biotechnol Adv. 2018;DOI:10.1016/j.biotechadv.2018.04.001. | |
dc.type.version | acceptedVersion | |
dc.citation.rank | aM21 |